by St. Jude Children’s Research Hospital A fast-acting anti-malarial compound discovered at St. Jude Children’s Research Hospital was well tolerated and showed promising anti-malarial effects in the first study in humans. The findings appear online first this week in the journal Lancet Infectious Diseases. “The results support further development of the compound SJ733 as a...
